Covance is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland. The facility increases Covance’s global capacity to approximately 550 beds in the U.S. and Europe. The company’s staff includes nine physicians as well as other medical staff. All Swiss Pharma Contract employees will be offered employment at Covance. Swiss Pharma Contract provides clinical research service...